A Survey of the Clinical, Off-Label Use of Ketamine as a Treatment for Psychiatric Disorders

AMERICAN JOURNAL OF PSYCHIATRY

AMER PSYCHIATRIC PUBLISHING, INC

1. NIMH [T32MH062994-15]
2. Brain and Behavior Research Foundation
3. Robert E. Leet and Clara Guthrie Patterson Trust
4. Allergan
5. Alkermes
6. AstraZeneca
7. Avanier Pharmaceuticals
8. BioHaven Pharmaceuticals
9. Bristol-Myers Squibb
10. Hoffmann La-Roche
11. Janssen
12. Merck
13. Naurex
14. Novartis
15. Noven Pharmaceuticals
16. Servier Pharmaceuticals
17. Taisho Pharmaceuticals
18. Teva
19. Valeant
20. Vistagen Therapeutics
21. Sanofi-Aventis
22. Eli Lilly
23. Johnson Johnson
24. Servier